Verrica Pharmaceuticals Statistics
Total Valuation
VRCA has a market cap or net worth of $83.61 million. The enterprise value is $98.25 million.
Important Dates
The last earnings date was Friday, November 14, 2025, before market open.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
VRCA has 9.49 million shares outstanding. The number of shares has increased by 89.19% in one year.
| Current Share Class | 9.49M |
| Shares Outstanding | 9.49M |
| Shares Change (YoY) | +89.19% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 87.98% |
| Owned by Institutions (%) | 9.85% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.52 |
| Forward PS | 2.47 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.19 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.25
| Current Ratio | 1.25 |
| Quick Ratio | 0.98 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.77 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -26.28% |
| Return on Invested Capital (ROIC) | -61.09% |
| Return on Capital Employed (ROCE) | -129.46% |
| Revenue Per Employee | $434,211 |
| Profits Per Employee | -$366,394 |
| Employee Count | 71 |
| Asset Turnover | 0.84 |
| Inventory Turnover | 4.16 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -25.97% in the last 52 weeks. The beta is 1.50, so VRCA's price volatility has been higher than the market average.
| Beta (5Y) | 1.50 |
| 52-Week Price Change | -25.97% |
| 50-Day Moving Average | 4.58 |
| 200-Day Moving Average | 5.48 |
| Relative Strength Index (RSI) | 70.61 |
| Average Volume (20 Days) | 378,377 |
Short Selling Information
The latest short interest is 446,691, so 4.71% of the outstanding shares have been sold short.
| Short Interest | 446,691 |
| Short Previous Month | 419,718 |
| Short % of Shares Out | 4.71% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.04 |
Income Statement
In the last 12 months, VRCA had revenue of $30.83 million and -$26.01 million in losses. Loss per share was -$2.96.
| Revenue | 30.83M |
| Gross Profit | 20.66M |
| Operating Income | -15.52M |
| Pretax Income | -26.01M |
| Net Income | -26.01M |
| EBITDA | -14.96M |
| EBIT | -15.52M |
| Loss Per Share | -$2.96 |
Full Income StatementBalance Sheet
The company has $21.10 million in cash and $35.74 million in debt, giving a net cash position of -$14.64 million or -$1.54 per share.
| Cash & Cash Equivalents | 21.10M |
| Total Debt | 35.74M |
| Net Cash | -14.64M |
| Net Cash Per Share | -$1.54 |
| Equity (Book Value) | -17.04M |
| Book Value Per Share | -1.80 |
| Working Capital | 7.37M |
Full Balance SheetCash Flow
| Operating Cash Flow | -29.10M |
| Capital Expenditures | n/a |
| Free Cash Flow | -29.10M |
| FCF Per Share | -$3.07 |
Full Cash Flow StatementMargins
Gross margin is 67.02%, with operating and profit margins of -50.34% and -84.38%.
| Gross Margin | 67.02% |
| Operating Margin | -50.34% |
| Pretax Margin | -84.38% |
| Profit Margin | -84.38% |
| EBITDA Margin | -48.52% |
| EBIT Margin | -50.34% |
| FCF Margin | n/a |